Streptococcus pneumoniae pharyngeal colonization in school-age children and adolescents with cancer

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 2, 2016, Pages 301-307

  Principi, Nicola ^a   Preti, Valentina ^a   Gaspari, Stefania ^b   Colombini, Antonella ^c   Zecca, Marco ^d   Terranova, Leonardo ^a   Cefalo, Maria Giuseppina ^b   Ierardi, Valentina ^a   Pelucchi, Claudio ^e   Esposito, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

cancer; children; pediatrics; pneumococcal conjugate vaccine; pneumococcal infection; pneumococcal vaccine; Streptococcus pneumoniae; tumor

Indexed keywords

COTRIMOXAZOLE; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; BACTERIAL DNA; VACCINE;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; CHILD; DNA EXTRACTION; DRUG EFFICACY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PHARYNX; PNEUMOCOCCAL INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SOLID TUMOR; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; GENETICS; HETEROZYGOTE; IMMUNOLOGY; MICROBIOLOGY; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; SEROTYPE; VACCINATION;

ADOLESCENT; CARRIER STATE; CHILD; DNA, BACTERIAL; FEMALE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; MALE; NASOPHARYNX; NEOPLASMS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; REAL-TIME POLYMERASE CHAIN REACTION; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; VACCINATION; VACCINES, CONJUGATE;

EID: 84960965703     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1090071     Document Type: Article

References (30)

1. G.R.Siber. Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae: their occurrence and course in children with cancer. Am J Dis Child 1980; 134:668-72; PMID:6967256; http://dx.doi.org/10.1001/archpedi.1980.02130190036009
2. J.B.Allen, L.B.Weiner. Pneumococcal sepsis in childhood leukemia and lymphoma. Pediatrics 1981; 67:292-5; PMID:7017572
3. M.A.Rose, D.Christopoulou, T.T.Myint, I.de Schutter. The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe. Int J Clin Pract 2014; 68:8-19; PMID:23869711; http://dx.doi.org/10.1111/ijcp.12234
4. A.J.van Hoek, N.Andrews, P.A.Waight, J.Stowe, P.Gates, R.George, E.Miller. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012; 65:17-24; PMID:22394683; http://dx.doi.org/10.1016/j.jinf.2012.02.017
5. R.Meisel, A.M.Toschke, C.Heiligensetzer, D.Dilloo, H.J.Laws, R.von Kries. Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia. Br J Haematol 2007; 137:457-60; PMID:17488489; http://dx.doi.org/10.1111/j.1365-2141.2007.06601.x
6. T.Hjuler, J.Wohlfahrt, M.Staum Kaltoft, A.Koch, R.J.Biggar, M.Melbye. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008; 122:e26-32; PMID:18595971; http://dx.doi.org/10.1542/peds.2007-1510
7. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2013; 62:521-4; PMID:23803961
8. M.Pao, E.B.Papadopoulos, J.Chou, H.Glenn, H.Castro-Malaspina, A.A.Jakubowski, N.A.Kernan, M.A.Perales, S.Prokop, A.Scaradavou, M.R.VanDenBrink, J.W.Young, R.J.O'Reilly, T.N.Small. Response to pneumococcal (PNCRM7) and Haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant 2008; 14:1022-30; PMID:18721765; http://dx.doi.org/10.1016/j.bbmt.2008.06.012
9. B.Simell, K.Auranen, H.Käyhty, D.Goldblatt, R.Dagan, K.L.O'Brien. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 2012; 11:841-55; PMID:22913260; http://dx.doi.org/10.1586/erv.12.53
10. S.M.Davis, M.Deloria-Knoll, H.T.Kassa, K.L.O'Brien. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 2013; 32:133-45; PMID:23684824; http://dx.doi.org/10.1016/j.vaccine.2013.05.005
11. Istituto Superiore di Sanità. Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute. Dati e evidenze disponibili per l'utilizzo dei vaccini anti-pneumococcici nei soggetti a rischio di qualsiasi età e per l'eventuale ampliamento dell'offerta ai soggetti anziani. : http://www.epicentro.iss.it/temi/vaccinazioni/pdf/Dati%20e%20evidenze%20vaccini%20antipneumococcici.pdf. Accessed on 30 April 2015.
12. N.Principi, S.Esposito. Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines. Hum Vaccin Immunother 2015; 11:1494-500; PMID:25970715; http://dx.doi.org/10.1080/21645515.2015.1033600
13. N.Principi, L.Terranova, A.Zampiero, F.Manzoni, L.Senatore, W.P.Rios, S.Esposito. Oropharyngeal and nasopharyngeal sampling for the detection of adolescent Streptococcus pneumoniae carriers. J Med Microbiol 2014; 63:393-8; PMID:24298049; http://dx.doi.org/10.1099/jmm.0.068726-0
14. F.S.Dube, M.Kaba, E.Whittaker, H.J.Zar, M.P.Nicol. Detection of Streptococcus pneumoniae from different types of nasopharyngeal swabs in children. PLoS One 2013; 8:e68097; PMID:23840817; http://dx.doi.org/10.1371/journal.pone.0068097
15. M.G.Carvalho, F.C.Pimenta, I.Moura, A.Roundtree, R.E.GertzJr, Z.Li, G.Jagero, G.Bigogo, M.Junghae, L.Conklin, D.R.Feikin, R.F.Breiman, C.G.Whitney, B.W.Beall. Non-pneumococcal mitis-group streptococci confound detection of pneumococcal capsular serotype-specific loci in upper respiratory tract. Peer J 2013; 1:e97; PMID:23825797; http://dx.doi.org/10.7717/peerj.97
16. V.Cvitkovic Spik, B.Beovic, M.Pokorn, A.Drole Torkar, D.Vidmar, L.Papst, K.Seme, R.Kogoj, M.Müller Premru. Improvement of pneumococcal pneumonia diagnostics by the use of rt-PCR on plasma and respiratory samples. Scand J Infect Dis 2013; 45:731-7; PMID:23826792; http://dx.doi.org/10.3109/00365548.2013.804631
17. H.K.Park, S.J.Lee, J.W.Yoon, J.W.Shin, H.S.Shin, J.K.Kook, S.C.Myung, W.Kim. Identification of the cpsA gene as a specific marker for the discrimination of Streptococcus pneumoniae from viridans group streptococci. J Med Microbiol 2010; 59:1146-52; PMID:20616191; http://dx.doi.org/10.1099/jmm.0.017798-0
18. T.Lehrnbecher, R.Schubert, M.Behl, M.Koenig, M.A.Rose, U.Koehl, R.Meisel, H.J.Laws. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia. Br J Haematol 2009; 147:700-5; PMID:19764991; http://dx.doi.org/10.1111/j.1365-2141.2009.07903.x
19. S.Mehr, Wood N Streptococcus pneumoniae - a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev 2012; 13:258-64; PMID:23069126; http://dx.doi.org/10.1016/j.prrv.2011.12.001
20. N.Principi, L.Terranova, A.Zampiero, V.Montinaro, V.Ierardi, E.Peves Rios, C.Pelucchi, S.Esposito. Pharyngeal colonisation by Streptococcus pneumoniae in older children and adolescents in a geographical area characterised by relatively limited pneumococcal vaccination coverage. Pediatr Infect Dis J 2015; 34:426-32; PMID:25760567; http://dx.doi.org/10.1097/INF.0000000000000637
21. A.Marchese, L.Gualco, I.Cochetti, M.P.Montanari, A.M.Speciale, S.R.Musumeci. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents 2005; 26:138-45; PMID:16024234; http://dx.doi.org/10.1016/j.ijantimicag.2005.04.006
22. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1071-4; PMID:19798021
23. K.P.Klugman. Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Lond B Biol Sci 2011; 366:2790-8; PMID:21893542; http://dx.doi.org/10.1098/rstb.2011.0032
24. S.Esposito, C.Colombo, A.Tosco, E.Montemitro, S.Volpi, L.Ruggiero, M.Lelii, A.Bisogno, C.Pelucchi, N.Principi; Italian pneumococcal study group on cystic fibrosis. Streptococcus pneumoniae oropharyngeal colonization in children and adolescents with cystic fibrosis. J Cyst Fibros. 2015 Jun 3; PMID:26049740
25. See comment in PubMed Commons below F.W.Cheng, M.Ip, Y.Y.Chu, Z.Lin, V.Lee, M.K.Shing, W.K.Leung, P.M.Yuen, C.K.Li. Humoral response to conjugate pneumococcal vaccine in paediatric oncology patients. Arch Dis Child 2012; 97:358-60; PMID:21109505; http://dx.doi.org/10.1136/adc.2010.198416
26. B.Simell, A.Nurkka, M.Lahdenkari, N.Givon-Lavi, H.Käyhty, R.Dagan, J.Jokinen. Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol 2012; 19:96-9; PMID:22072724; http://dx.doi.org/10.1128/CVI.05369-11
27. N.J.Andrews, P.A.Waight, P.Burbidge, E.Pearce, L.Roalfe, M.Zancolli, M.Slack, S.N.Ladhani, E.Miller, D.Goldblatt. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis 2014; 14:839-46; PMID:25042756; http://dx.doi.org/10.1016/S1473-3099(14)70822-9
28. Ministero della Salute. Piano Nazionale Vaccini 2005–2007. : http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=543. Accessed 30 April 2015.
29. A.Marchese, S.Esposito, E.Coppo, G.A.Rossi, A.Tozzi, M.Romano, L.Da Dalt, G.C.Schito, N.Principi. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children <=5 years of age with community-acquired pneumonia. Microb Drug Resist 2011; 17:419-24; PMID:21510746; http://dx.doi.org/10.1089/mdr.2011.0031
30. S.Esposito, A.Marchese, A.E.Tozzi, G.A.Rossi, L.Da Dalt, G.Bona, C.Pelucchi, G.C.Schito, N.Principi; Italian Pneumococcal CAP Group. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Pediatr Infect Dis J 2012; 31:705-10; PMID:22426300; http://dx.doi.org/10.1097/INF.0b013e31825384ae